FDA Approves New Prostate Cancer Detection Tool
The Food and Drug Administration has approved the production and use of choline C-11, an imaging agent used in positron emission tomography (PET) to detect prostate cancer. The compound is injected intravenously, and the FDA has found that it is virtually free of side effects, except for some mild skin irritation at the injection site […]
min read